Impact of the Pro12Ala Polymorphism of the PPAR‐Gamma 2 Gene on Metabolic and Clinical Characteristics in the Palestinian Type 2 Diabetic Patients
Open Access
- 1 January 2009
- journal article
- research article
- Published by Wiley in PPAR Research
- Vol. 2009 (1) , 874126
Abstract
Peroxisome proliferators activated receptor‐gamma2 (PPARγ2) represents the transcriptional master regulator of adipocyte differentiation and therefore has been suggested as a candidate gene for obesity, insulin resistance, and dyslipidemia. The objective of the study was to investigate for the first time the potential association of the most common variant Pro12Ala (p.P12A) substitution of the PPAR γ2 gene with body mass index (BMI), blood pressure, fasting plasma glucose, plasma total cholesterol, LDL and HDL cholesterol, and plasma triglyceride in a sample of 202 (138 females and 64 male) type 2 diabetic Palestinians. Genotyping of the PPAR γ2 p.P12A polymorphism was determined by polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) analysis. The A12 allele was associated with lower fasting plasma glucose (P = .03) but had no influence on blood pressure, BMI, or other metabolic parameters. In obese patients, the p.P12A substitution was associated with elevated total plasma cholesterol levels (P = .02) and a tendency toward increased LDL cholesterol level (P = .06). In conclusion, the p.P12A variant of the PPAR γ2 may influence cardiovascular risk through effects on lipid metabolism in obese T2D Palestinian patients.Keywords
This publication has 27 references indexed in Scilit:
- PPARγ2Pro12Ala Polymorphism and Human HealthPPAR Research, 2009
- Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic DisordersPPAR Research, 2008
- SNPs in PPARG Associate with Type 2 Diabetes and Interact with Physical ActivityMedicine & Science in Sports & Exercise, 2008
- Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous populationActa Diabetologica, 2007
- Type-2 diabetes: a cocktail of genetic discoveryHuman Molecular Genetics, 2006
- Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes‐related traits in UK samplesDiabetic Medicine, 2005
- The peroxisome proliferator activated receptorφ2 (PPARφ2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patientsDiabetes & Metabolism, 2005
- Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian populationJournal of Lipid Research, 2004
- The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 DiabetesBiochemical and Biophysical Research Communications, 2000
- Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes MellitusBiochemical and Biophysical Research Communications, 1999